Raymond James Financial Inc Crispr Therapeutics Ag Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Raymond James Financial Inc holds 82,095 shares of CRSP stock, worth $3.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,095Holding current value
$3.33 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
59.1MCall Options Held
1.09MPut Options Held
1.9M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$364 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA7.93MShares$322 Million0.07% of portfolio
-
State Street Corp Boston, MA2.99MShares$122 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$120 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$113 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.17B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....